Saadat, Lily V.
Goldman, Debra A.
Kalvin, Hannah
Gonen, Mithat
Soares, Kevin C.
Wei, Alice C.
Balachandran, Vinod P.
Kingham, T. Peter
Drebin, Jeffrey
Jarnagin, William R.
D’Angelica, Michael I.
Article History
First Online: 1 September 2025
Disclosure
: COI provided. All other authors certify that they have no affiliations with or involvement in any organization with any financial interest in the subject matter discussed in this manuscript. J.D. reports employment and leadership at American Regent (spouse), and stock and other ownership interests in Alnylam, Arrowhead Pharmaceuticals, and Ions pharmaceuticals. A.C.W. reports consulting fees from Histosonics and institutional research funding from Ipsen.